TD Waterhouse Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TD Waterhouse Canada's BMY Position: Q2 2026 in Review
TD Waterhouse Canada increased its Bristol-Myers Squibb (BMY) stake by 195% in Q2 2026, buying an estimated $3.09M and bringing the position to 81,526 shares worth $4.61M. The position accounts for 0.01% of the portfolio, ranked #427.
TD Waterhouse Canada first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $27.1M in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TD Waterhouse Canada held 81,526 shares of Bristol-Myers Squibb worth $4.61M as of Q2 2026.
- TD Waterhouse Canada bought 53,881 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.09M.
- Bristol-Myers Squibb made up 0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #427 holding.
- TD Waterhouse Canada first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's Bristol-Myers Squibb position peaked at $27.1M in Q2 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.